We are live on
!
Find out more
Aristotle Capital Management Portfolio holdings
AUM
$47.8B
1-Year Est. Return
13.38%
This Fund
S&P 500
This Quarter
Est. Return
+2.79%
1 Year Est. Return
+13.38%
3 Year Est. Return
+48.4%
5 Year Est. Return
+59.36%
10 Year Est. Return
+297.67%
AUM
$8.05B
AUM Growth
+$235M
(+3%)
Cap. Flow
+$79.9M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
31.17%
Holding
146
New
6
Increased
30
Reduced
58
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$253M |
| 2 |
Novartis
NVS
|
+$162M |
| 3 |
National Fuel Gas
NFG
|
+$95.8M |
| 4 |
BOK Financial
BOKF
|
+$21.1M |
| 5 |
Oshkosh
OSK
|
+$19.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HSP
HOSPIRA INC
HSP
|
+$200M |
| 2 |
General Mills
GIS
|
+$136M |
| 3 |
Coty
COTY
|
+$43.5M |
| 4 |
Ecolab
ECL
|
+$24.3M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$18.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.61% |
| 2 | Consumer Discretionary | 13.86% |
| 3 | Financials | 11.84% |
| 4 | Industrials | 11.79% |
| 5 | Healthcare | 11.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MJN
126
DELISTED
Mead Johnson Nutrition Company
MJN
| $260K | ﹤0.01% |
2,584
| – | – |
|
127
Honeywell
HON
$77B
| $254K | ﹤0.01% |
2,708
+37
| +1% | +$3.39K |
|
128
Caterpillar
CAT
$375B
| $235K | ﹤0.01% |
2,933
| – | – |
|
129
IBM
IBM
$211B
| $235K | ﹤0.01% |
1,532
| – | – |
|
130
Citigroup
C
$222B
| $225K | ﹤0.01% |
4,369
+99
| +2% | +$5.04K |
|
131
Intel
INTC
$455B
| $210K | ﹤0.01% |
6,700
-1,000
| -13% | -$33.7K |
|
132
iShares MSCI South Korea ETF
EWY
$21.9B
| $206K | ﹤0.01% |
3,600
-300
| -8% | -$16.9K |
|
133
GSK
GSK
$104B
| $206K | ﹤0.01% |
3,570
-800
| -18% | -$45.9K |
|
134
Stryker
SYK
$125B
| $203K | ﹤0.01% |
2,200
| – | – |
|
135
AT&T
T
$159B
| $201K | ﹤0.01% |
8,149
| – | – |
|
136
Air Products & Chemicals
APD
$65.7B
| – | – |
-2,151
| Closed | -$287K |
|
137
Barclays
BCS
$92.7B
| – | – |
-301,862
| Closed | -$4.21M |
|
138
NextEra Energy
NEE
$181B
| – | – |
-10,720
| Closed | -$285K |
|
139
Progressive
PGR
$123B
| – | – |
-8,705
| Closed | -$235K |
|
140
Transocean
RIG
$5.89B
| – | – |
-28,795
| Closed | -$528K |
|
141
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
| – | – |
-487,600
| Closed | -$10.6M |
|
|
CRR
142
DELISTED
Carbo Ceramics Inc.
CRR
| – | – |
-5,200
| Closed | -$208K |
|
|
SIAL
143
DELISTED
SIGMA - ALDRICH CORP
SIAL
| – | – |
-2,133
| Closed | -$293K |
|
|
HSP
144
DELISTED
HOSPIRA INC
HSP
| – | – |
-3,261,205
| Closed | -$200M |
|
|
TRW
145
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
| – | – |
-6,515
| Closed | -$670K |
|
|
COV
146
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| – | – |
-14,141
| Closed | -$1.45M |
|
Similar funds
TI
RIM
Aristotle Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Aristotle Capital Management held 146 positions worth $8.05B, up 3% from $7.81B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Aristotle Capital Management's Q1 2015 filing shows 6 new, 30 increased, 58 reduced and 11 closed positions. Its largest new stake was Medtronic: 3,333,075 shares worth $260M. The largest sale was HOSPIRA INC, an estimated $200M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- Aristotle Capital Management's largest Q1 2015 buy was Medtronic: 3,333,075 shares worth $260M.
- Aristotle Capital Management added most to Novartis in Q1 2015, an estimated $162M increase.
- Aristotle Capital Management's biggest Q1 2015 reduction was General Mills, cutting an estimated $136M.
- Aristotle Capital Management fully exited HOSPIRA INC in Q1 2015, selling an estimated $200M.
- Aristotle Capital Management's ten largest holdings make up 31% of its $8.05B portfolio in Q1 2015.
- Aristotle Capital Management opened 6 new positions and closed 11 in Q1 2015.
- Aristotle Capital Management's portfolio value rose 3% quarter-over-quarter to $8.05B.
Based on Aristotle Capital Management's 13F filing for Q1 2015, filed 15 May 2015.